Markus Schmid

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 4

Top Topics

Cell Proliferation

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Science translational medicine

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Nicole Kirchhammer, Marcel Philipp Trefny, Marina Natoli, Dominik Brücher, Sheena N Smith, Franziska Werner, Victoria Koch, David Schreiner, Ewelina Magdalena Bartoszek, Mélanie Buchi, Markus Schmid, Daniel Breu, K Patricia Hartmann, Polina Zaytseva, Daniela S Thommen, Heinz Laubli, Jan Philipp Böttcher, Michal A Stanczak, Abhishek S Kashyap, Andreas Plückthun, Alfred Zippelius
NK cells with tissue-resident traits shape response to immunotherapy by inducing adaptive antitumor immunity. Science translational medicine 14 (653) (2022)
Sheena N Smith, Rajib Schubert, Branko Simic, Dominik Brücher, Markus Schmid, Niels Kirk, Patrick C Freitag, Viviana Gradinaru, Andreas Plückthun
The SHREAD gene therapy platform for paracrine delivery improves tumor localization and intratumoral effects of a clinical antibody. Proceedings of the National Academy of Sciences of the United States of America 118 (21) (2021)
Nicole Stichling, Maarit Suomalainen, Justin W Flatt, Markus Schmid, Martin Pacesa, Silvio Hemmi, Wolfgang Jungraithmayr, Mareike D Maler, Marina A Freudenberg, Andreas Plückthun, Tobias May, Mario Köster, György Fejer, Urs F Greber
Lung macrophage scavenger receptor SR-A6 (MARCO) is an adenovirus type-specific virus entry receptor. PLoS pathogens 14 (3) (2018)
Markus Schmid, Patrick Ernst, Annemarie Honegger, Maarit Suomalainen, Martina Zimmermann, Lukas Braun, Sarah Stauffer, Cristian Thom, Birgit Dreier, Matthias Eibauer, Anja Kipar, Viola Vogel, Urs F Greber, Ohad Medalia, Andreas Plückthun
Adenoviral vector with shield and adapter increases tumor specificity and escapes liver and immune control. Nature communications 9 (1) (2018)